Ardent Health Partners ARDT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.5%-0.1pp | 97.5%0.0pp | 97.6%+0.1pp | 97.6%+0.1pp | 97.6%+0.1pp | |
| Net margin | 2.1%-1.6pp | 2.1%-1.4pp | 3.2%+1.6pp | 4.1%+2.5pp | 3.7%+2.3pp | |
| EBITDA margin | 7.8%-2.0pp | 7.9%-1.8pp | 9%+1.7pp | 10.1%+2.8pp | 9.8%— | |
| Free cash flow margin | 3.4%+1.4pp | 4.1%+2.0pp | 2.5%+0.7pp | 1.7%-0.3pp | 2%— | |
| Returns | ||||||
| Return on equity | 10.7%-9.0pp | 11.2%-12.1pp | 18.3%+9.1pp | 25.6%+15.5pp | 19.7%+12.2pp | |
| Return on assets | 2.6%— | 2.7%-1.7pp | 4.1%— | 5.3%— | —— | |
| Return on invested capital | 14.6%— | 9.4%-6.7pp | 20.5%— | 22.8%— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.3×— | 1.2×0.0× | 1.3×— | 1.3×— | —— | |
| Inventory turnover | 1.4×-1.1× | 1.3×0.0× | 1.3×— | 1.3×— | 2.4×— | |
| Liquidity | ||||||
| Current ratio | 2.1×0.0× | 2×0.0× | 2.1×+0.2× | 2.1×+0.5× | 2.1×— | |
| Quick ratio | 2×0.0× | 1.9×0.0× | 1.9×+0.2× | 2×+0.5× | 2×— | |
| Cash ratio | 0.6×0.0× | 0.7×+0.1× | 0.6×0.0× | 0.6×+0.2× | 0.6×— | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.1× | 1.8×-0.2× | 0.9×-0.2× | 0.9×-0.6× | 1×— | |
| Debt-to-assets | 0.2×0.0× | 0.4×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×— | |
| Net debt / EBITDA | 1.1×0.0× | 3.3×+0.3× | 1×-0.4× | 1×-0.9× | 1.1×— | |
| Interest coverage | 6.4×-0.9× | 6.2×-0.3× | 7.4×+3.5× | 8.4×+4.8× | 7.3×+3.9× | |
| Per Share | ||||||
| Book value per share | $9.43+12.9% | $9.11+6.8% | $8.77+19.9% | $8.87+51.1% | $8.35-5.1% | |
| Valuation | ||||||
| Market capitalization | $1.35B-27.8% | $1.26B-48.1% | $1.9B— | $1.89B— | $1.96B— | |
| Enterprise value | $1.91B-24.3% | $2.92B-30.4% | $2.44B— | $2.5B— | $2.62B— | |
| Price / earnings | 10×+1.7× | 9.3×-2.3× | 9.2×— | 7.4×— | 8.7×— | |
| Price / sales | 0.2×-0.1× | 0.2×-0.2× | 0.3×— | 0.3×— | 0.3×— | |
| Price / book | 1×-0.6× | 1×-1.2× | 1.5×— | 1.5×— | 1.7×— | |
| EV / EBITDA | 3.8×-0.5× | 5.9×-1.4× | 4.3×— | 4×— | 4.5×— | |
| EV / sales | 0.3×-0.1× | 0.5×-0.2× | 0.4×— | 0.4×— | 0.4×— | |
| Free cash flow yield | 16.2%+9.8pp | 20.5%+15.2pp | 8.3%— | 5.7%— | 6%— | |
| Earnings yield | 10%-2.1pp | 10.7%+2.1pp | 10.8%— | 13.5%— | 11.4%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Ardent Health Partners's ratios come from?
- Every ratio is computed from Ardent Health Partners's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
